IRCT20190602043787N3RecruitingPhase 3
Evaluation of the effect of Ivermectin in hospitalized patients with COVID-19 in Imam Reza Hospital in Mashhad
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 16 years to 75 years (—)
- Sex
- All
Inclusion Criteria
- •Covid-19 patients whose diagnosis is confirmed by clinical signs of patients and other laboratory parameters,are checked:physicians clinical diagnosis includes the patients general condition and clinical symptoms.
- •O2 saturation less than 93% in infected patients
- •laboratory parameters(ESR,CRP,Ferrittin,CBC,Lymph count,D-dimer(if present))
- •Positive Real time PCR test result for Covid-19
- •Patients in the age range of 16-75 years
Exclusion Criteria
- •Pregnancy and breastfeeding
- •Concomitant use of warfarin
- •Patients over 75 years old
Investigators
Similar Trials
Completed
Phase 2
Ivermectin in COVIDCTRI/2020/06/026001AIIMS New Delhi125
Recruiting
Phase 3
Effect of Ivermectin in treatment of COVID-19COVID-19 disease.COVID-19, virus not identifiedU07.2IRCT20200506047323N6Bandare-abbas University of Medical Sciences120
Recruiting
Not Applicable
Efficacy of Ivermectin in the treatment of COVID-19IRCT20210901052358N4Shahid Beheshti University of Medical Sciences60
Recruiting
Phase 3
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375
Completed
Phase 1
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49